Q12962 (TAF10_HUMAN) Homo sapiens (Human)
Transcription initiation factor TFIID subunit 10 UniProtKBInterProSTRINGInteractive Modelling
218 aa; Sequence (Fasta) ;
1 identical sequence: Pan troglodytes: A0A2J8P6C7
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of transcribing complex 9 (TC9), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| TFIID-based intermediate PIC on PUMA promoter |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | 10×ZN; 1×MG; | |||
| TFIID in rearranged conformation |
Heteromer O00268; P20226; P21675; P49848; P52655; P52657; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Structure of transcribing complex 5 (TC5), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| TFIID lobe A subcomplex |
Heteromer O00268; P20226; P49848; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9; | 100.0 | ||||
| Structure of transcribing complex 8 (TC8), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| Cryo-EM structure of the human SAGA coactivator complex (TRRAP, core) |
Heteromer O15265; O75486; O75529; O94864; Q16514; Q8NEM7; Q96BN2; Q9HBM6; Q9Y4A5; Q9Y6J9; | 100.0 | 1×IHP; | |||
| Structure of transcribing complex 6 (TC6), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| Negative stain EM structure of the human SAGA coactivator complex (TRRAP, core, splicing module) |
Heteromer F2Z2U4; O15265; O75486; O75529; O94864; Q15393; Q16514; Q8NEM7; Q96BN2; Q9BWJ5; Q9HBM6; Q9Y6J9; | 100.0 | ||||
| TFIID-based core PIC on PUMA promoter |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | 9×ZN; 1×MG; | |||
| SCP promoter-bound TFIID-TFIIA in initial TBP-loading state |
Heteromer O00268; P20226; P21675; P49848; P52655; P52657; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Structure of transcribing complex 3 (TC3), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×W0F; 1×MG; | |||
| Structure of transcribing complex 4 (TC4), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| p53-bound TFIID-based core PIC on HDM2 promoter |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | 9×ZN; 1×MG; | |||
| TFIID-based intermediate PIC on SCP promoter |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P21675; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | 10×ZN; 1×MG; | |||
| TFIID in canonical conformation |
Heteromer O00268; P20226; P21675; P49848; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| SCP promoter-bound TFIID-TFIIA in post TBP-loading state |
Heteromer O00268; P20226; P21675; P49848; P52655; P52657; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Structure of transcribing complex 2 (TC2), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×W0F; 1×MG; | |||
| Structure of transcribing complex 7 (TC7), the initially transcribing complex with Pol II positione… |
Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; 1×W0F; | |||
| TFIID-based holo PIC on SCP promoter |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 17×ZN; 1×SF4; 1×MG; | |||
| TFIID-based core PIC on SCP promoter |
Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P21675; P35269; P49848; P52655; P52657; P60899; Q00403; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | 9×ZN; 1×MG; | |||
| p53-bound TFIID-based holo PIC on HDM2 promoter |
Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759; | 100.0 | 16×ZN; 1×SF4; 1×MG; | |||
| TFIID lobe B subcomplex |
Heteromer O00268; P49848; Q15542; Q16514; Q16594; Q7Z7C8; | 100.0 | ||||
| Cryo-EM structure of the human SAGA complex |
Heteromer O15265; O75486; O75529; O94864; Q15393; Q16514; Q16594; Q8NEM7; Q96BN2; Q9BWJ5; Q9Y4A5; Q9Y6J9; | 100.0 | ||||
| Heterodimer of TAF8/TAF10 |
Heteromer Q7Z7C8; | 100.0 | 1×GOL; 1×CL; | |||
| Human TFIID bound to promoter DNA and TFIIA |
Heteromer O00268; P20226; P21675; P49848; P52655; P52657; Q15542; Q15545; Q16514; Q16594; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Human TFIID canonical state |
Heteromer O00268; P20226; P21675; P49848; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Human TFIID BC core |
Heteromer O00268; P49848; Q15542; Q16514; Q16594; Q6P1X5; Q7Z7C8; | 100.0 | ||||
| Human TFIID Lobe A canonical |
Heteromer O00268; P20226; P21675; P49848; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9; | 100.0 | ||||
| Ternary complex of SET7/9 bound to AdoHcy and a TAF10 peptide |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 Y245A in complex with TAF10-K189me1 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; 2×SO4; | |||
| SET7/9 Y305F in complex with TAF10 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 Y245A in complex with TAF10-K189me2 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; 3×CO; 4×GOL; | |||
| SET7/9 Y245A in complex with TAF10 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; 1×GOL; | |||
| SET7/9 Y245A in complex with TAF10-K189me3 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; 7×CO; 3×GOL; | |||
| SET7/9 in complex with TAF10 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 Y305F in complex with TAF10-K189me1 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 in complex with TAF10K189A peptide and AdoHcy |
Heteromer Q8WTS6; | 85.71 | 1×SAH; | |||
| SET7/9 N265A in complex with AdoHcy and TAF10 peptide |
Heteromer Q8WTS6; | 100 | 1×SAH; 1×NA; | |||
| SET7/9Y335pAF in complex with TAF10 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 Y305F in complex with TAF10-K189me2 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
| SET7/9 in complex with TAF10K189A peptide and AdoMet |
Heteromer Q8WTS6; | 83.33 | 1×SAM; | |||
| SET7/9Y335F in complex with TAF10 peptide and AdoHcy |
Heteromer Q8WTS6; | 100 | 1×SAH; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7kts.1.H | monomer | 0.63 | 100.00 | |||
| 7lmy.1.A | monomer | 0.54 | 12.00 | |||